BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27085674)

  • 21. Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease.
    Lu T; Connolly PJ; Philippar U; Sun W; Cummings MD; Barbay K; Gys L; Van Nuffel L; Austin N; Bekkers M; Shen F; Cai A; Attar R; Meerpoel L; Edwards J
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126743. PubMed ID: 31678006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of recombinant and cellular MALT1 paracaspase activity.
    Nagel D; Krappmann D
    Methods Mol Biol; 2015; 1280():239-46. PubMed ID: 25736752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short Communication: Preferential Killing of HIV Latently Infected CD4(+) T Cells by MALT1 Inhibitor.
    Li H; He H; Gong L; Fu M; Wang TT
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):174-7. PubMed ID: 26728103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface.
    Cabalzar K; Pelzer C; Wolf A; Lenz G; Iwaszkiewicz J; Zoete V; Hailfinger S; Thome M
    PLoS One; 2013; 8(8):e72051. PubMed ID: 23977204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells.
    Zhu L; Tang F; Lei Z; Guo C; Song Y; Huang J; Xia X
    Mol Carcinog; 2019 Dec; 58(12):2340-2352. PubMed ID: 31556968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The paracaspase MALT1: biological function and potential for therapeutic inhibition.
    Jaworski M; Thome M
    Cell Mol Life Sci; 2016 Feb; 73(3):459-73. PubMed ID: 26507244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.
    Douanne T; Gavard J; Bidère N
    J Cell Sci; 2016 May; 129(9):1775-80. PubMed ID: 27006117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical Probes for Profiling of MALT1 Protease Activity.
    Verhelst SHL; Prothiwa M
    Chembiochem; 2023 Nov; 24(21):e202300444. PubMed ID: 37607867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
    Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
    Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probes to monitor activity of the paracaspase MALT1.
    Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
    Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Potent, Highly Selective, and
    Pissot Soldermann C; Simic O; Renatus M; Erbel P; Melkko S; Wartmann M; Bigaud M; Weiss A; McSheehy P; Endres R; Santos P; Blank J; Schuffenhauer A; Bold G; Buschmann N; Zoller T; Altmann E; Manley PW; Dix I; Buchdunger E; Scesa J; Quancard J; Schlapbach A; Bornancin F; Radimerski T; Régnier CH
    J Med Chem; 2020 Dec; 63(23):14576-14593. PubMed ID: 33252239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
    Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
    J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of the
    Quancard J; Simic O; Pissot Soldermann C; Aichholz R; Blatter M; Renatus M; Erbel P; Melkko S; Endres R; Sorge M; Kieffer L; Wagner T; Beltz K; Mcsheehy P; Wartmann M; Régnier CH; Calzascia T; Radimerski T; Bigaud M; Weiss A; Bornancin F; Schlapbach A
    J Med Chem; 2020 Dec; 63(23):14594-14608. PubMed ID: 33216547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies.
    Liang X; Cao Y; Li C; Yu H; Yang C; Liu H
    Med Res Rev; 2021 Jul; 41(4):2388-2422. PubMed ID: 33763890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of API2-MALT1 fusion gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas and diffuse large B cell lymphomas].
    Li BZ; Lu HF; Sheng WQ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):765-8. PubMed ID: 20079017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Backbone Assignment of the MALT1 Paracaspase by Solution NMR.
    Unnerståle S; Nowakowski M; Baraznenok V; Stenberg G; Lindberg J; Mayzel M; Orekhov V; Agback T
    PLoS One; 2016; 11(1):e0146496. PubMed ID: 26788853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of API2-MALT1 fusion gene in extranodal B-cell lymphoma and its significance].
    Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):92-6. PubMed ID: 16630483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A patent review of MALT1 inhibitors (2013-present).
    Hamp I; O'Neill TJ; Plettenburg O; Krappmann D
    Expert Opin Ther Pat; 2021 Dec; 31(12):1079-1096. PubMed ID: 34214002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
    Yang W; Li Y; Li P; Wang L
    Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.